The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bacteria-derived Microbial Drugs Market Research Report 2025
Synopsis
The global Bacteria-derived Microbial Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bacteria-derived Microbial Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bacteria-derived Microbial Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bacteria-derived Microbial Drugs include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma and Second Genome, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bacteria-derived Microbial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteria-derived Microbial Drugs.
Report Scope
The Bacteria-derived Microbial Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bacteria-derived Microbial Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacteria-derived Microbial Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
Rebiotix
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Osel
Segment by Type
Oral Dosage Form
Enteric Capsules
Segment by Application
Gastrointestinal Disorders
Autoimmune Disorders
Diabetes
Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacteria-derived Microbial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacteria-derived Microbial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Bacteria-derived Microbial Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bacteria-derived Microbial Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bacteria-derived Microbial Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bacteria-derived Microbial Drugs include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma and Second Genome, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bacteria-derived Microbial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteria-derived Microbial Drugs.
Report Scope
The Bacteria-derived Microbial Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bacteria-derived Microbial Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacteria-derived Microbial Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
Rebiotix
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Osel
Segment by Type
Oral Dosage Form
Enteric Capsules
Segment by Application
Gastrointestinal Disorders
Autoimmune Disorders
Diabetes
Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacteria-derived Microbial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacteria-derived Microbial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bacteria-derived Microbial Drugs Market Overview
1.1 Product Overview and Scope of Bacteria-derived Microbial Drugs
1.2 Bacteria-derived Microbial Drugs Segment by Type
1.2.1 Global Bacteria-derived Microbial Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral Dosage Form
1.2.3 Enteric Capsules
1.3 Bacteria-derived Microbial Drugs Segment by Application
1.3.1 Global Bacteria-derived Microbial Drugs Market Value by Application: (2024-2030)
1.3.2 Gastrointestinal Disorders
1.3.3 Autoimmune Disorders
1.3.4 Diabetes
1.3.5 Cancer
1.3.6 Others
1.4 Global Bacteria-derived Microbial Drugs Market Size Estimates and Forecasts
1.4.1 Global Bacteria-derived Microbial Drugs Revenue 2019-2030
1.4.2 Global Bacteria-derived Microbial Drugs Sales 2019-2030
1.4.3 Global Bacteria-derived Microbial Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bacteria-derived Microbial Drugs Market Competition by Manufacturers
2.1 Global Bacteria-derived Microbial Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bacteria-derived Microbial Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bacteria-derived Microbial Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Bacteria-derived Microbial Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bacteria-derived Microbial Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bacteria-derived Microbial Drugs, Product Type & Application
2.7 Bacteria-derived Microbial Drugs Market Competitive Situation and Trends
2.7.1 Bacteria-derived Microbial Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bacteria-derived Microbial Drugs Players Market Share by Revenue
2.7.3 Global Bacteria-derived Microbial Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bacteria-derived Microbial Drugs Retrospective Market Scenario by Region
3.1 Global Bacteria-derived Microbial Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bacteria-derived Microbial Drugs Global Bacteria-derived Microbial Drugs Sales by Region: 2019-2030
3.2.1 Global Bacteria-derived Microbial Drugs Sales by Region: 2019-2024
3.2.2 Global Bacteria-derived Microbial Drugs Sales by Region: 2025-2030
3.3 Global Bacteria-derived Microbial Drugs Global Bacteria-derived Microbial Drugs Revenue by Region: 2019-2030
3.3.1 Global Bacteria-derived Microbial Drugs Revenue by Region: 2019-2024
3.3.2 Global Bacteria-derived Microbial Drugs Revenue by Region: 2025-2030
3.4 North America Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.4.1 North America Bacteria-derived Microbial Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bacteria-derived Microbial Drugs Sales by Country (2019-2030)
3.4.3 North America Bacteria-derived Microbial Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.5.1 Europe Bacteria-derived Microbial Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bacteria-derived Microbial Drugs Sales by Country (2019-2030)
3.5.3 Europe Bacteria-derived Microbial Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Bacteria-derived Microbial Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bacteria-derived Microbial Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Bacteria-derived Microbial Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.7.1 Latin America Bacteria-derived Microbial Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bacteria-derived Microbial Drugs Sales by Country (2019-2030)
3.7.3 Latin America Bacteria-derived Microbial Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Bacteria-derived Microbial Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bacteria-derived Microbial Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bacteria-derived Microbial Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bacteria-derived Microbial Drugs Sales by Type (2019-2030)
4.1.1 Global Bacteria-derived Microbial Drugs Sales by Type (2019-2024)
4.1.2 Global Bacteria-derived Microbial Drugs Sales by Type (2025-2030)
4.1.3 Global Bacteria-derived Microbial Drugs Sales Market Share by Type (2019-2030)
4.2 Global Bacteria-derived Microbial Drugs Revenue by Type (2019-2030)
4.2.1 Global Bacteria-derived Microbial Drugs Revenue by Type (2019-2024)
4.2.2 Global Bacteria-derived Microbial Drugs Revenue by Type (2025-2030)
4.2.3 Global Bacteria-derived Microbial Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Bacteria-derived Microbial Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bacteria-derived Microbial Drugs Sales by Application (2019-2030)
5.1.1 Global Bacteria-derived Microbial Drugs Sales by Application (2019-2024)
5.1.2 Global Bacteria-derived Microbial Drugs Sales by Application (2025-2030)
5.1.3 Global Bacteria-derived Microbial Drugs Sales Market Share by Application (2019-2030)
5.2 Global Bacteria-derived Microbial Drugs Revenue by Application (2019-2030)
5.2.1 Global Bacteria-derived Microbial Drugs Revenue by Application (2019-2024)
5.2.2 Global Bacteria-derived Microbial Drugs Revenue by Application (2025-2030)
5.2.3 Global Bacteria-derived Microbial Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Bacteria-derived Microbial Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Seres Therapeutics
6.1.1 Seres Therapeutics Corporation Information
6.1.2 Seres Therapeutics Description and Business Overview
6.1.3 Seres Therapeutics Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Seres Therapeutics Bacteria-derived Microbial Drugs Product Portfolio
6.1.5 Seres Therapeutics Recent Developments/Updates
6.2 Assembly Biosciences
6.2.1 Assembly Biosciences Corporation Information
6.2.2 Assembly Biosciences Description and Business Overview
6.2.3 Assembly Biosciences Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Assembly Biosciences Bacteria-derived Microbial Drugs Product Portfolio
6.2.5 Assembly Biosciences Recent Developments/Updates
6.3 Synthetic Biologics
6.3.1 Synthetic Biologics Corporation Information
6.3.2 Synthetic Biologics Description and Business Overview
6.3.3 Synthetic Biologics Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Synthetic Biologics Bacteria-derived Microbial Drugs Product Portfolio
6.3.5 Synthetic Biologics Recent Developments/Updates
6.4 Interxon
6.4.1 Interxon Corporation Information
6.4.2 Interxon Description and Business Overview
6.4.3 Interxon Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Interxon Bacteria-derived Microbial Drugs Product Portfolio
6.4.5 Interxon Recent Developments/Updates
6.5 PureTech
6.5.1 PureTech Corporation Information
6.5.2 PureTech Description and Business Overview
6.5.3 PureTech Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 PureTech Bacteria-derived Microbial Drugs Product Portfolio
6.5.5 PureTech Recent Developments/Updates
6.6 Synlogic
6.6.1 Synlogic Corporation Information
6.6.2 Synlogic Description and Business Overview
6.6.3 Synlogic Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Synlogic Bacteria-derived Microbial Drugs Product Portfolio
6.6.5 Synlogic Recent Developments/Updates
6.7 Enterome BioScience
6.6.1 Enterome BioScience Corporation Information
6.6.2 Enterome BioScience Description and Business Overview
6.6.3 Enterome BioScience Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Enterome BioScience Bacteria-derived Microbial Drugs Product Portfolio
6.7.5 Enterome BioScience Recent Developments/Updates
6.8 4D Pharma
6.8.1 4D Pharma Corporation Information
6.8.2 4D Pharma Description and Business Overview
6.8.3 4D Pharma Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 4D Pharma Bacteria-derived Microbial Drugs Product Portfolio
6.8.5 4D Pharma Recent Developments/Updates
6.9 Second Genome
6.9.1 Second Genome Corporation Information
6.9.2 Second Genome Description and Business Overview
6.9.3 Second Genome Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Second Genome Bacteria-derived Microbial Drugs Product Portfolio
6.9.5 Second Genome Recent Developments/Updates
6.10 AOBiome
6.10.1 AOBiome Corporation Information
6.10.2 AOBiome Description and Business Overview
6.10.3 AOBiome Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AOBiome Bacteria-derived Microbial Drugs Product Portfolio
6.10.5 AOBiome Recent Developments/Updates
6.11 Rebiotix
6.11.1 Rebiotix Corporation Information
6.11.2 Rebiotix Bacteria-derived Microbial Drugs Description and Business Overview
6.11.3 Rebiotix Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Rebiotix Bacteria-derived Microbial Drugs Product Portfolio
6.11.5 Rebiotix Recent Developments/Updates
6.12 Metabiomics
6.12.1 Metabiomics Corporation Information
6.12.2 Metabiomics Bacteria-derived Microbial Drugs Description and Business Overview
6.12.3 Metabiomics Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Metabiomics Bacteria-derived Microbial Drugs Product Portfolio
6.12.5 Metabiomics Recent Developments/Updates
6.13 Ritter Pharmaceuticals
6.13.1 Ritter Pharmaceuticals Corporation Information
6.13.2 Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Description and Business Overview
6.13.3 Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Product Portfolio
6.13.5 Ritter Pharmaceuticals Recent Developments/Updates
6.14 Symberix
6.14.1 Symberix Corporation Information
6.14.2 Symberix Bacteria-derived Microbial Drugs Description and Business Overview
6.14.3 Symberix Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Symberix Bacteria-derived Microbial Drugs Product Portfolio
6.14.5 Symberix Recent Developments/Updates
6.15 OpenBiome
6.15.1 OpenBiome Corporation Information
6.15.2 OpenBiome Bacteria-derived Microbial Drugs Description and Business Overview
6.15.3 OpenBiome Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 OpenBiome Bacteria-derived Microbial Drugs Product Portfolio
6.15.5 OpenBiome Recent Developments/Updates
6.16 Azitra
6.16.1 Azitra Corporation Information
6.16.2 Azitra Bacteria-derived Microbial Drugs Description and Business Overview
6.16.3 Azitra Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Azitra Bacteria-derived Microbial Drugs Product Portfolio
6.16.5 Azitra Recent Developments/Updates
6.17 Osel
6.17.1 Osel Corporation Information
6.17.2 Osel Bacteria-derived Microbial Drugs Description and Business Overview
6.17.3 Osel Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Osel Bacteria-derived Microbial Drugs Product Portfolio
6.17.5 Osel Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bacteria-derived Microbial Drugs Industry Chain Analysis
7.2 Bacteria-derived Microbial Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bacteria-derived Microbial Drugs Production Mode & Process
7.4 Bacteria-derived Microbial Drugs Sales and Marketing
7.4.1 Bacteria-derived Microbial Drugs Sales Channels
7.4.2 Bacteria-derived Microbial Drugs Distributors
7.5 Bacteria-derived Microbial Drugs Customers
8 Bacteria-derived Microbial Drugs Market Dynamics
8.1 Bacteria-derived Microbial Drugs Industry Trends
8.2 Bacteria-derived Microbial Drugs Market Drivers
8.3 Bacteria-derived Microbial Drugs Market Challenges
8.4 Bacteria-derived Microbial Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
